212 related articles for article (PubMed ID: 11071656)
1. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.
Riemersma SA; Jordanova ES; Schop RF; Philippo K; Looijenga LH; Schuuring E; Kluin PM
Blood; 2000 Nov; 96(10):3569-77. PubMed ID: 11071656
[TBL] [Abstract][Full Text] [Related]
2. Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.
Jordanova ES; Riemersma SA; Philippo K; Giphart-Gassler M; Schuuring E; Kluin PM
Genes Chromosomes Cancer; 2002 Sep; 35(1):38-48. PubMed ID: 12203788
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma.
Jordanova ES; Philippo K; Giphart MJ; Schuuring E; Kluin PM
Immunogenetics; 2003 Jul; 55(4):203-9. PubMed ID: 12756506
[TBL] [Abstract][Full Text] [Related]
4. The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.
Riemersma SA; Jordanova ES; Haasnoot GW; Drabbels J; Schuuring E; Schreuder GM; Kluin PM
Hum Immunol; 2006; 67(4-5):303-10. PubMed ID: 16720210
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma.
Booman M; Douwes J; Glas AM; Riemersma SA; Jordanova ES; Kok K; Rosenwald A; de Jong D; Schuuring E; Kluin PM
Clin Cancer Res; 2006 May; 12(9):2698-705. PubMed ID: 16675561
[TBL] [Abstract][Full Text] [Related]
6. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
7. Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.
Jordanova ES; Riemersma SA; Philippo K; Schuuring E; Kluin PM
Int J Cancer; 2003 Jan; 103(3):393-8. PubMed ID: 12471623
[TBL] [Abstract][Full Text] [Related]
8. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
[TBL] [Abstract][Full Text] [Related]
9. Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations.
Minderman M; Amir A; Kraan W; Schilder-Tol EJM; Oud MECM; Scheepstra CG; Noorduyn AL; Kluin PM; Kersten MJ; Spaargaren M; Pals ST
Blood; 2021 Sep; 138(13):1194-1197. PubMed ID: 34125179
[No Abstract] [Full Text] [Related]
10. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Rodriguez T; Méndez R; Roberts CH; Ruiz-Cabello F; Dodi IA; López Nevot MA; Paco L; Maleno I; Marsh SG; Pawelec G; Garrido F
Cancer Immunol Immunother; 2005 Feb; 54(2):141-8. PubMed ID: 15592718
[TBL] [Abstract][Full Text] [Related]
11. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
12. Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma.
Bosga-Bouwer AG; Kok K; Booman M; Boven L; van der Vlies P; van den Berg A; van den Berg E; de Jong B; Poppema S; Kluin P
Genes Chromosomes Cancer; 2006 Oct; 45(10):976-81. PubMed ID: 16865685
[TBL] [Abstract][Full Text] [Related]
13. [Organization of the chromosomic region of the major human histocompatibility complex].
Vernet C; Sidibé I; Pontarotti P
Pathol Biol (Paris); 1992 Oct; 40(8):822-30. PubMed ID: 1484743
[No Abstract] [Full Text] [Related]
14. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
15. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
16. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
King RL; Goodlad JR; Calaminici M; Dotlic S; Montes-Moreno S; Oschlies I; Ponzoni M; Traverse-Glehen A; Ott G; Ferry JA
Virchows Arch; 2020 May; 476(5):647-665. PubMed ID: 31863183
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.
Medeiros LJ; Gelb AB; Wolfson K; Doggett R; McGregor B; Cox RS; Horning SJ; Warnke RA
Am J Pathol; 1993 Oct; 143(4):1086-97. PubMed ID: 8214004
[TBL] [Abstract][Full Text] [Related]
18. Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all endogenous class II genes.
Cheng S; Smart M; Hanson J; David CS
J Autoimmun; 2003 Nov; 21(3):195-9. PubMed ID: 14599844
[TBL] [Abstract][Full Text] [Related]
19. Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma.
Robertus JL; Harms G; Blokzijl T; Booman M; de Jong D; van Imhoff G; Rosati S; Schuuring E; Kluin P; van den Berg A
Mod Pathol; 2009 Apr; 22(4):547-55. PubMed ID: 19287466
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism at expressed DQ and DR loci in five common equine MHC haplotypes.
Miller D; Tallmadge RL; Binns M; Zhu B; Mohamoud YA; Ahmed A; Brooks SA; Antczak DF
Immunogenetics; 2017 Mar; 69(3):145-156. PubMed ID: 27889800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]